Vascular smooth muscle cell-derived adiponectin: A paracrine regulator of contractile phenotype

Abstract 

Adiponectin is a cardioprotective adipokine derived predominantly from visceral fat. We recently demonstrated that exogenous adiponectin induces vascular smooth muscle cell (VSMC) differentiation via repression of mTORC1 and FoxO4. Here we report for the first time that VSMC express and secrete adiponectin, which acts in an autocrine and paracrine manner to regulate VSMC contractile phenotype. Adiponectin was found to be expressed in human coronary artery and mouse aortic VSMC. Importantly, siRNA knock-down of endogenous adiponectin in VSMC significantly reduced the expression of VSMC contractile proteins. Contractile protein deficiency was also observed in primary VSMC isolated from Adiponectin^−/− mice. This deficiency could be rescued by culturing Adiponectin^−/− VSMC in conditioned media from wild type (WT) VSMC. Moreover, the paracrine effect of VSMC-derived adiponectin was confirmed as adiponectin neutralizing antibody blocked the rescue. Overexpressed adiponectin also exerted paracrine effects on neighboring untransfected VSMC, which was also blocked by adiponectin neutralizing antibody. Interestingly, adiponectin expression was inducible by the PPARγ agonist rosiglitazone. Our data support an important role for VSMC-derived adiponectin in maintaining VSMC contractile phenotype, contributing to critical cardioprotective functions in the vascular wall. This article is part of a Special Issue entitled “Local Signaling in Myocytes”.

Graphical abstract 

Abbreviations: VSMC, vascular smooth muscle cell(s), hCASMC, human coronary artery smooth muscle cell(s), ER, endoplasmic reticulum, Adpn, adiponectin, Rosi, Rosiglitazone

Keywords: Adiponectin, Vascular smooth muscle, Contractile proteins, Contractile phenotype, Autocrine, Paracrine